Consumer Goods | National Investor Network

CBD Companies Should Continue to See Growth, Despite FDA Crackdowns

Written by Jason Sanders | Dec 31, 2019 7:04:53 PM

Despite the FDA recently cracking down on companies selling CBD products as dietary supplements investing experts are predicting continued growth in the niche market of the overall cannabis industry.

Experts from the Bright Field Group, a research firm for the cannabis industry, are predicting CBD revenue to surpass $23.7 billion by 2023. Companies selling CBD products like Charlotte's Web (OTC: CWBHF) will look to FDA officials for guidance as to how to be compliant and avoid penalties or further crackdowns.